Using data from the St. Jude Lifetime Cohort (St. Jude LIFE), Yadav Sapkota, PhD, St. Jude Department of Epidemiology and Cancer Control, designed a 27-protein model capable of accurately estimating treatment-related cardiomyopathy risk in pediatric cancer survivors.